Regentis Biomaterials (RGNT) Price to Book (2025)
Regentis Biomaterials' (RGNT) quarterly Price to Book came in at 0.81 in Q4 2025.
Powered by 
Analysis
Regentis Biomaterials (RGNT) Price to Book (2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Price to Book for 1 consecutive years, with 0.81 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Price to Book changed N/A year-over-year to 0.81 in Q4 2025; TTM through Dec 2025 was 0.81, a N/A change from a year earlier, with the FY2025 full-year figure at 0.81, changed N/A from the prior year.
- Price to Book was 0.81 for Q4 2025 at Regentis Biomaterials.
- Over five years, Price to Book peaked at 0.81 in Q4 2025 and troughed at 0.81 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Regentis Biomaterials | 1.12 Mn | -6.26 Mn | - |